Important practice-points for pharmacists independently initiating and furnishing Paxlovid
Natalia Mazina
AUGUST 16, 2022
Recently – on July 6, 2022 – the FDA amended the Emergency Use Authorization (EUA) for Paxlovid, an orally-administered COVID-19 therapeutic drug. Recently – on July 6, 2022 – the FDA amended the Emergency Use Authorization (EUA) for Paxlovid, an orally-administered COVID-19 therapeutic drug.
Let's personalize your content